3-Dinor-11Beta-Prostaglandin F2 Alpha, Urine 24 hour or Random

Overview

  • EPIC Code:
  • MISC
  • Soft Test Code:
  • MSOT
  • Send Out Test Code:
  • 23BPR Random and 23BPT 24hr
Alternate Names
  • 11 Beta-Prostaglandin F2 Alpha
  • 11BPG
  • 2,3 11 Beta-Prostaglandin F2 Alpha
  • 2,3-dinor 11B-Prostaglandin F2a, U
  • 23BPG
  • BPG2
  • Mastocytosis
  • Prostaglandin
Clinical Significance

Screening for mast cell activation disorders including systemic mastocytosis


Specimen Collection & Preparation

Patient Preparation

Patients taking aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) may have decreased concentrations of prostaglandin F2 alpha. If possible, discontinue for 2 weeks or 72 hours, respectively, prior to collecting a specimen.


Specimen Requirements

 5.0 mL aliquot from a well mixed 24 hour Urine Collection in a Plastic Container

Alternate Specimen

5.0 mL Urine collected in an Sterile Gray
1. Collect a random urine specimen. 
2. Refrigerate specimen after collection. Send specimen refrigerated or frozen; do not add any preservative.

 

TransportAndStorage

8 hours Ambient
14 days Refrigerated - Preferred
30 daus Frozen

Collection Instructions

1. When starting the 24-hour period, urinate and discard (throw-away) this specimen. NOTE THE TIME 
2. From that time on, collect all urine by urinating into a clean container and transfer into the provided container. 
DO NOT URINATE DIRECTLY INTO CONTAINER. 
3. Try to pass the last urine just prior to the end of the 24 hour period. Add this urine into the container. 
4. Urine Specimen should be kept refrigerated during and after collection. 

For patient collection instruction sheet see Addendum D
For Spanish patient collection instruction sheet see Addendum D
For Burmese patient collection instruction sheet see Addendum D
For Arabic patient collection instruction sheet see Addendum D

Clinical Interpretation

Reference Range:

Refer to interpretative results


Test Comments:

When this test is performed, urine creatinine will always be performed at no additional charge


Methodology:
  • Enzymatic Colorimetric Assay
  • LC-MS/MS

Clinical Significance

Screening for mast cell activation disorders including systemic mastocytosis


Production Schedule

Sites Performed
  • Mayo Laboratory
Days Performed
Monday
Thursday
Departments
  • Sendouts - Miscellaneous
Turn Around Time

2 to 7 days


Coding & Compliance

CDM

00913334


CPT Coding

84150